leon-nanodrugs GmbH (LEON), a provider of nanotechnology for the pharmaceutical industry, has completed its reactor development. With all prerequisites set for serial production, the proprietary reactor will now provide inter-device reproducibility of nanoparticle features. This is a technological breakthrough for production of LNPs, as well as for encapsulation of transfection material (such as mRNA) or active pharmaceutical ingredients (APIs), at any stage of preclinical and clinical developme...